BMC Neurology

Table 3 Usage rates of medical treatment categories and relapse PPPM (values in 2016 were adjusted)

From: Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database

PPPM			2008	2009	2010	2011	2012	2013	2014	2015	2016
Inpatient			0.053	0.049	0.042	0.036	0.037	0.036	0.032	0.032	0.030
Outpatient			1.06	1.07	1.08	0.99	0.95	0.90	0.91	0.86	0.83
Imaging			0.17	0.17	0.14	0.13	0.14	0.16	0.15	0.13	0.13
Lab test			0.75	0.90	0.71	0.68	0.71	0.68	0.64	0.65	0.62
Prescription drug	Relapse treatment	Number of prescription	0.44	0.46	0.33	0.32	0.26	0.17	0.17	0.15	0.15
	DMT	Number of prescription	0.39	0.33	0.40	0.39	0.34	0.39	0.40	0.36	0.35
		Days supplied/Prescription	18.07	20.82	16.06	16.13	19.46	21.58	23.56	28.31	28.64
		total days supplied	7.06	6.84	6.45	6.22	6.55	8.34	9.46	10.12	9.98
	Others	Number of prescription	7.74	8.20	7.91	7.20	6.45	5.88	5.75	5.73	5.65
Relapse			0.032	0.036	0.031	0.031	0.025	0.024	0.023	0.020	0.019

Back to article page

ISSN: 1471-2377

Contact us

General enquiries: journalsubmissions@springernature.com